2023 Q1 Form 10-K Financial Statement
#000155837023003035 Filed on March 07, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $26.07M | $51.28M | $120.2M |
YoY Change | 55.78% | 151.25% | -19.43% |
Cost Of Revenue | $977.0K | $342.0K | $1.749M |
YoY Change | 707.44% | -29.77% | 61.5% |
Gross Profit | $25.09M | $50.94M | $118.5M |
YoY Change | 51.04% | 155.68% | -20.02% |
Gross Profit Margin | 96.25% | 99.33% | 98.55% |
Selling, General & Admin | $27.73M | $32.17M | $112.5M |
YoY Change | 1.2% | 31.23% | 22.37% |
% of Gross Profit | 110.5% | 63.16% | 94.9% |
Research & Development | $10.09M | $15.37M | $60.27M |
YoY Change | -34.8% | 15.49% | -7.61% |
% of Gross Profit | 40.21% | 30.17% | 50.87% |
Depreciation & Amortization | $357.0K | $284.0K | $998.0K |
YoY Change | 50.63% | -29.7% | -16.83% |
% of Gross Profit | 1.42% | 0.56% | 0.84% |
Operating Expenses | $37.82M | $47.54M | $172.7M |
YoY Change | -11.79% | 25.7% | 9.93% |
Operating Profit | -$12.73M | $3.399M | -$55.55M |
YoY Change | -51.54% | -118.99% | 344.54% |
Interest Expense | $1.204M | -$678.0K | $3.707M |
YoY Change | -0.08% | -47.16% | -23.72% |
% of Operating Profit | -19.95% | ||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | -$13.54M | $1.401M | -$58.57M |
YoY Change | -50.68% | -106.17% | 238.4% |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | 0.0% | ||
Net Earnings | -$13.54M | $1.401M | -$58.57M |
YoY Change | -50.68% | -106.19% | 226.97% |
Net Earnings / Revenue | -51.92% | 2.73% | -48.71% |
Basic Earnings Per Share | -$0.08 | -$0.34 | |
Diluted Earnings Per Share | -$0.08 | $0.01 | -$0.34 |
COMMON SHARES | |||
Basic Shares Outstanding | 173.7M | 172.8M | 172.4M |
Diluted Shares Outstanding | 173.6M | 172.4M |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $58.66M | $58.21M | $58.21M |
YoY Change | -45.44% | -53.42% | -53.42% |
Cash & Equivalents | $40.29M | $24.46M | $24.46M |
Short-Term Investments | $18.38M | $33.75M | $33.75M |
Other Short-Term Assets | $7.867M | $8.259M | $8.259M |
YoY Change | -16.44% | 11.43% | 11.43% |
Inventory | $11.08M | $9.118M | $9.118M |
Prepaid Expenses | |||
Receivables | $29.37M | $40.32M | $40.32M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $107.0M | $115.9M | $115.9M |
YoY Change | -23.01% | -24.97% | -24.97% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $294.0K | $857.0K | $2.787M |
YoY Change | -86.26% | -60.76% | -76.55% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $542.0K | $640.0K | $640.0K |
YoY Change | 16.81% | -34.29% | -34.29% |
Total Long-Term Assets | $16.64M | $18.38M | $18.38M |
YoY Change | 64.17% | 42.88% | 42.88% |
TOTAL ASSETS | |||
Total Short-Term Assets | $107.0M | $115.9M | $115.9M |
Total Long-Term Assets | $16.64M | $18.38M | $18.38M |
Total Assets | $123.6M | $134.3M | $134.3M |
YoY Change | -17.08% | -19.75% | -19.75% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $6.295M | $22.51M | $22.51M |
YoY Change | 36.43% | 493.1% | 493.1% |
Accrued Expenses | $18.15M | $24.19M | $24.19M |
YoY Change | -55.66% | 575.75% | -44.59% |
Deferred Revenue | $1.369M | $1.369M | |
YoY Change | -34.72% | -47.27% | |
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $45.52M | $65.21M | $65.21M |
YoY Change | -23.14% | 2.61% | 2.61% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $59.48M | $39.45M | $39.45M |
YoY Change | 99.3% | 98.09% | 98.09% |
Other Long-Term Liabilities | $42.07M | $42.26M | $43.24M |
YoY Change | -20.94% | -19.84% | -19.16% |
Total Long-Term Liabilities | $42.07M | $42.26M | $82.68M |
YoY Change | -20.94% | -19.84% | 12.65% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $45.52M | $65.21M | $65.21M |
Total Long-Term Liabilities | $42.07M | $42.26M | $82.68M |
Total Liabilities | $147.9M | $147.9M | $147.9M |
YoY Change | 31.52% | 27.19% | 7.99% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$1.396B | -$1.382B | |
YoY Change | 3.31% | 4.42% | |
Common Stock | $1.372B | $1.369B | |
YoY Change | 0.97% | 1.08% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$24.26M | -$13.62M | -$13.62M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $123.6M | $134.3M | $134.3M |
YoY Change | -17.08% | -19.75% | -19.75% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$13.54M | $1.401M | -$58.57M |
YoY Change | -50.68% | -106.19% | 226.97% |
Depreciation, Depletion And Amortization | $357.0K | $284.0K | $998.0K |
YoY Change | 50.63% | -29.7% | -16.83% |
Cash From Operating Activities | -$4.074M | -$21.91M | -$73.76M |
YoY Change | -84.11% | 14.79% | -1354.81% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $15.00M | $73.00K | $450.0K |
YoY Change | 6596.43% | 247.62% | -28.23% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $15.78M | $18.67M | $73.23M |
YoY Change | -30.96% | 188.71% | -192.21% |
Cash From Investing Activities | $777.0K | $18.60M | $72.78M |
YoY Change | -96.57% | 186.65% | -190.93% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 19.12M | -2.096M | 6.550M |
YoY Change | 117.38% | -293.18% | -89.55% |
NET CHANGE | |||
Cash From Operating Activities | -4.074M | -21.91M | -73.76M |
Cash From Investing Activities | 777.0K | 18.60M | 72.78M |
Cash From Financing Activities | 19.12M | -2.096M | 6.550M |
Net Change In Cash | 15.83M | -5.407M | 5.569M |
YoY Change | 173.38% | -53.04% | -148.5% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$4.074M | -$21.91M | -$73.76M |
Capital Expenditures | $15.00M | $73.00K | $450.0K |
Free Cash Flow | -$19.07M | -$21.98M | -$74.21M |
YoY Change | -26.24% | 15.05% | -1513.22% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.34 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.11 | |
CY2020 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.18 | |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
172406000 | |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
170492000 | |
CY2020 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
168754000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
||
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
||
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001034842 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
RIGEL PHARMACEUTICALS INC | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | rigl |
Net Sublease Income Expense
NetSubleaseIncomeExpense
|
||
CY2021 | rigl |
Net Sublease Income Expense
NetSubleaseIncomeExpense
|
||
CY2020 | rigl |
Net Sublease Income Expense
NetSubleaseIncomeExpense
|
||
CY2022 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
171602226 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
173398645 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y6M | |
CY2022 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y6M18D | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
000-29889 | |
CY2022Q4 | rigl |
Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
|
7708000 | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
94-3248524 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
611 Gateway Boulevard, Suite 900, | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
South San Francisco | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
94080 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
650 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
624-1100 | |
CY2022 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $.001 per share | |
CY2022 | dei |
Trading Symbol
TradingSymbol
|
RIGL | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
true | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
193700000 | |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
173653353 | |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
42 | |
CY2022 | dei |
Auditor Name
AuditorName
|
Ernst & Young LLP | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
San Francisco, California | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
24459000 | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
18890000 | |
CY2022Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
33747000 | |
CY2021Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
106077000 | |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
40320000 | |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
15472000 | |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
9118000 | |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
6616000 | |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
8259000 | |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
7412000 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
115903000 | |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
154467000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
857000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2184000 | |
CY2022Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
14949000 | |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1930000 | |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
9703000 | |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
640000 | |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
974000 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
134279000 | |
CY2021Q4 | us-gaap |
Assets
Assets
|
167328000 | |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
22508000 | |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3795000 | |
CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
8866000 | |
CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
10690000 | |
CY2021Q4 | rigl |
Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
|
10384000 | |
CY2022Q4 | us-gaap |
Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
|
12145000 | |
CY2021Q4 | us-gaap |
Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
|
7915000 | |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
6485000 | |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
4776000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1133000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
9892000 | |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1369000 | |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
2596000 | |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
4997000 | |
CY2021Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
13506000 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
65211000 | |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
63554000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
972000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
759000 | |
CY2022Q4 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
39448000 | |
CY2021Q4 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
19914000 | |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
42264000 | |
CY2021Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
52727000 | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
147895000 | |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
136954000 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
173398645 | |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
171602226 | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
174000 | |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
172000 | |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1368822000 | |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1354190000 | |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-153000 | |
CY2021Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-102000 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1382459000 | |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1323886000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13616000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
30374000 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
134279000 | |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
167328000 | |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
120242000 | |
CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
149236000 | |
CY2020 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
108621000 | |
CY2022 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1749000 | |
CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1083000 | |
CY2020 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
895000 | |
CY2021 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-98000 | |
CY2022 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
60272000 | |
CY2021 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
65237000 | |
CY2020 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
60101000 | |
CY2022 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
112451000 | |
CY2021 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
91891000 | |
CY2020 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
76598000 | |
CY2022 | us-gaap |
Restructuring Charges
RestructuringCharges
|
1320000 | |
CY2021 | us-gaap |
Restructuring Charges
RestructuringCharges
|
3521000 | |
CY2022 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
175792000 | |
CY2021 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
161732000 | |
CY2020 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
137594000 | |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-55550000 | |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12496000 | |
CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-28973000 | |
CY2022 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
684000 | |
CY2021 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
47000 | |
CY2020 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
582000 | |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
3707000 | |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
4860000 | |
CY2020 | us-gaap |
Interest Expense
InterestExpense
|
1353000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-58573000 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-17309000 | |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-29744000 | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
605000 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-58573000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-17914000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-29744000 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.34 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.11 | |
CY2020 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.18 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
172406000 | |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
170492000 | |
CY2020 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
168754000 | |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-58573000 | |
CY2021 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-17914000 | |
CY2020 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-29744000 | |
CY2022 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-51000 | |
CY2021 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-98000 | |
CY2020 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-27000 | |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-58624000 | |
CY2021 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-18012000 | |
CY2020 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-29771000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
53815000 | |
CY2020 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-29744000 | |
CY2020 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-27000 | |
CY2020 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
2596000 | |
CY2020 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
7386000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
34026000 | |
CY2021 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-17914000 | |
CY2021 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
4775000 | |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
9585000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
30374000 | |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-58573000 | |
CY2022 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-51000 | |
CY2022 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
2124000 | |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
12510000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13616000 | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-58573000 | |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-17914000 | |
CY2020 | us-gaap |
Profit Loss
ProfitLoss
|
-29744000 | |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
12385000 | |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
9486000 | |
CY2020 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7297000 | |
CY2022 | rigl |
Net Gain Sale And Write Down Property And Equipment
NetGainSaleAndWriteDownPropertyAndEquipment
|
138000 | |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
998000 | |
CY2021 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1162000 | |
CY2020 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
706000 | |
CY2022 | rigl |
Noncash Interest Expense
NoncashInterestExpense
|
682000 | |
CY2021 | rigl |
Noncash Interest Expense
NoncashInterestExpense
|
3139000 | |
CY2022 | us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
63000 | |
CY2021 | us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
-287000 | |
CY2020 | us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
122000 | |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
24848000 | |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-501000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
5862000 | |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
2377000 | |
CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
4875000 | |
CY2020 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
126000 | |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
847000 | |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-6633000 | |
CY2020 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
4583000 | |
CY2022 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-334000 | |
CY2021 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
150000 | |
CY2020 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
128000 | |
CY2022 | rigl |
Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
|
7773000 | |
CY2021 | rigl |
Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
|
8192000 | |
CY2020 | rigl |
Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
|
7814000 | |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
3788000 | |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
41000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-331000 | |
CY2022 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-1824000 | |
CY2021 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
1098000 | |
CY2020 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
773000 | |
CY2022 | rigl |
Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
|
-2676000 | |
CY2021 | rigl |
Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
|
5495000 | |
CY2020 | rigl |
Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
|
-1071000 | |
CY2022 | rigl |
Revenue Reserves And Refund Liability
RevenueReservesAndRefundLiability
|
4230000 | |
CY2021 | rigl |
Revenue Reserves And Refund Liability
RevenueReservesAndRefundLiability
|
1850000 | |
CY2020 | rigl |
Revenue Reserves And Refund Liability
RevenueReservesAndRefundLiability
|
2733000 | |
CY2022 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
1709000 | |
CY2021 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-24000 | |
CY2020 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
1318000 | |
CY2022 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-8546000 | |
CY2021 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-8621000 | |
CY2020 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-7230000 | |
CY2022 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-1227000 | |
CY2021 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-422000 | |
CY2020 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-23629000 | |
CY2022 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-4538000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-73758000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
5878000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-52185000 | |
CY2022 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
28894000 | |
CY2021 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
141459000 | |
CY2020 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
81706000 | |
CY2022 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
101228000 | |
CY2021 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
62050000 | |
CY2020 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
130434000 | |
CY2022 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
893000 | |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
450000 | |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
627000 | |
CY2020 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1262000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
72777000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-80036000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
47466000 | |
CY2021 | rigl |
Cost Share Advance From Collaboration Partner
CostShareAdvanceFromCollaborationPartner
|
57900000 | |
CY2022 | rigl |
Payment Of Cost Share To Collaboration Partner
PaymentOfCostShareToCollaborationPartner
|
15116000 | |
CY2022 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
2124000 | |
CY2021 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
4775000 | |
CY2020 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
2596000 | |
CY2022 | us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
19542000 | |
CY2020 | us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
9975000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
6550000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
62675000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12571000 | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
5569000 | |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-11483000 | |
CY2020 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
7852000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
18890000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
30373000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
22521000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
24459000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
18890000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
30373000 | |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2495000 | |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1500000 | |
CY2020 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1180000 | |
CY2022 | rigl |
Intangible Assets Incurred But Not Yet Paid
IntangibleAssetsIncurredButNotYetPaid
|
15000000 | |
CY2022 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
58200000 | |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-top:12pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates and assumptions made by management include those relating to revenue recognition on product sales and collaboration agreements, recoverability of our assets, including accounts receivables and inventories, stock-based compensation and the probability of achievement of corporate performance-based milestones for our performance-based </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">stock option awards, impairment issues, the weighted average incremental borrowing rate for our lease, estimated interest rate for our financing liability, the estimated useful life of assets, and estimated accruals, particularly research and development accruals, on an ongoing basis. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. To the extent there are material differences between these estimates and actual results, our financial statements will be affected. </p> | |
CY2022 | us-gaap |
Reclassifications
Reclassifications
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reclassifications</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"/>We presented revenue reserves and refund liability on the face of balance sheets, which was previously classified within other accrued liabilities. The prior period financial information has been reclassified to conform with the current period presentation. </p> | |
CY2022 | rigl |
Share Based Compensation Arrangement By Share Based Payment Award Options Number Of Homogenous Groups For Determining Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNumberOfHomogenousGroupsForDeterminingFairValue
|
3 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2021Q4 | rigl |
Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
|
106000 | |
CY2020Q4 | rigl |
Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
|
171000 | |
CY2019Q4 | rigl |
Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
|
109000 | |
CY2022 | rigl |
Customer Allowance For Prompt Payment Discounts Period Increase
CustomerAllowanceForPromptPaymentDiscountsPeriodIncrease
|
557000 | |
CY2021 | rigl |
Customer Allowance For Prompt Payment Discounts Period Increase
CustomerAllowanceForPromptPaymentDiscountsPeriodIncrease
|
609000 | |
CY2020 | rigl |
Customer Allowance For Prompt Payment Discounts Period Increase
CustomerAllowanceForPromptPaymentDiscountsPeriodIncrease
|
807000 | |
CY2022 | rigl |
Customer Allowance For Prompt Payment Discounts Period Decrease
CustomerAllowanceForPromptPaymentDiscountsPeriodDecrease
|
527000 | |
CY2021 | rigl |
Customer Allowance For Prompt Payment Discounts Period Decrease
CustomerAllowanceForPromptPaymentDiscountsPeriodDecrease
|
674000 | |
CY2020 | rigl |
Customer Allowance For Prompt Payment Discounts Period Decrease
CustomerAllowanceForPromptPaymentDiscountsPeriodDecrease
|
745000 | |
CY2022Q4 | rigl |
Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
|
136000 | |
CY2021Q4 | rigl |
Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
|
106000 | |
CY2020Q4 | rigl |
Customer Allowance For Prompt Payment Discounts
CustomerAllowanceForPromptPaymentDiscounts
|
171000 | |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:12pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject us to a concentration of credit risk are primarily cash, investment in debt securities and accounts receivable. All of our cash and investment in debt securities are maintained with financial institutions that management believes are creditworthy. By policy, we limit the concentration of credit risk by diversifying our investments among a variety of high credit-quality issuers. Due to the short-term nature of these investments, we believe we do not have a material exposure to credit risk arising from our investments. We have not historically experienced any significant credit losses related to these financial instruments and do not believe that we are exposed to any significant credit risk related to these instruments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Concentration of credit risk with respect to our accounts receivable is limited due to our small number of customers. Our accounts receivable consists mostly of outstanding invoices from our sale of our product to our specialty distributors. Accounts receivable may also include outstanding invoice or invoices from our collaboration partners with respect to the related sponsored research and license agreements, as well as outstanding invoice or invoices from the US Government with respect to the related government contract. Our outstanding receivable as of December 31, 2022 includes $20.0 million of regulatory milestone due from Kissei which was collected in January 2023. As of December 31, 2022, 49% of our accounts receivable are outstanding invoices from our specialty distributors, and the remaining 51% are outstanding invoices from other collaboration partners, mainly Kissei and Grifols. As of December 31, 2021, 85% of our accounts receivable consisted of outstanding invoices from our specialty distributors, and the remaining 15% are outstanding invoices from the US Government and from other collaboration partners, mainly Grifols and Kissei.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">See “Note 3 - Revenues” for summary of revenues from each of our customers who individually accounted for 10% or more of the total net product sales and revenues from collaborations. </p> | |
CY2022 | us-gaap |
Advertising Expense
AdvertisingExpense
|
2700000 | |
CY2021 | us-gaap |
Advertising Expense
AdvertisingExpense
|
2300000 | |
CY2020 | us-gaap |
Advertising Expense
AdvertisingExpense
|
1700000 | |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
35800000 | |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
30235000 | |
CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
27260000 | |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
120242000 | |
CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
149236000 | |
CY2020 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
108621000 | |
CY2021Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
7915000 | |
CY2022 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
30903000 | |
CY2022 | us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
26673000 | |
CY2022Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
12145000 | |
CY2020Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
6065000 | |
CY2021 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
16788000 | |
CY2021 | us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
14938000 | |
CY2021Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
7915000 | |
CY2022 | rigl |
Sales Discounts And Allowances
SalesDiscountsAndAllowances
|
31800000 | |
CY2022 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
30900000 | |
CY2021 | rigl |
Sales Discounts And Allowances
SalesDiscountsAndAllowances
|
18200000 | |
CY2021 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
16800000 | |
CY2021 | rigl |
Collaborative Arrangement Upfront Fee Received
CollaborativeArrangementUpfrontFeeReceived
|
125000000.0 | |
CY2022 | us-gaap |
Accretion Expense
AccretionExpense
|
700000 | |
CY2021 | us-gaap |
Accretion Expense
AccretionExpense
|
2800000 | |
CY2021Q4 | rigl |
Financing Liability Including Interest Expense Accretion
FinancingLiabilityIncludingInterestExpenseAccretion
|
60700000 | |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
12385000 | |
CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
9486000 | |
CY2020 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
7295000 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
|
1400000 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
|
400000 | |
CY2022 | rigl |
Number Of Active Equity Plans
NumberOfActiveEquityPlans
|
2 | |
CY2022Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
14100000 | |
CY2022Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
4555000 | |
CY2021Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
5142000 | |
CY2022Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
2659000 | |
CY2021Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
162000 | |
CY2022Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1904000 | |
CY2021Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1312000 | |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
9118000 | |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
6616000 | |
CY2022Q4 | us-gaap |
Advances On Inventory Purchases
AdvancesOnInventoryPurchases
|
800000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
58206000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
124967000 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
24459000 | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
18890000 | |
CY2022Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
33747000 | |
CY2021Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
106077000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
58206000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
124967000 | |
CY2022Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
47940000 | |
CY2022Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
47787000 | |
CY2021Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
111978000 | |
CY2021Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
111876000 | |
CY2022 | rigl |
Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
|
P89D | |
CY2021 | rigl |
Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
|
P96D | |
CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
|
0 | |
CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
|
36 | |
CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
46313000 | |
CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
154000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
11664000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
16735000 | |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
10807000 | |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
14551000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
857000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2184000 | |
CY2022 | rigl |
Depreciation And Amortization Expense
DepreciationAndAmortizationExpense
|
900000 | |
CY2021 | rigl |
Depreciation And Amortization Expense
DepreciationAndAmortizationExpense
|
1200000 | |
CY2020 | rigl |
Depreciation And Amortization Expense
DepreciationAndAmortizationExpense
|
700000 | |
CY2022 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
700000 | |
CY2022 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P14Y | |
CY2022 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
100000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
1071000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
1071000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
1071000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
1071000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
1071000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
9594000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
14949000 | |
CY2022Q4 | rigl |
Accrued Commercial Expenses Current
AccruedCommercialExpensesCurrent
|
3144000 | |
CY2021Q4 | rigl |
Accrued Commercial Expenses Current
AccruedCommercialExpensesCurrent
|
1949000 | |
CY2022Q4 | rigl |
Accrued Other Expenses Current
AccruedOtherExpensesCurrent
|
3341000 | |
CY2021Q4 | rigl |
Accrued Other Expenses Current
AccruedOtherExpensesCurrent
|
2827000 | |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
6485000 | |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
4776000 | |
CY2022Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
5000000 | |
CY2022Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
20000000 | |
CY2022Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
15000000 | |
CY2022Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
40000000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
739000 | |
CY2022Q4 | rigl |
Lessee Operating Lease Liability Net Payments Due Year Two
LesseeOperatingLeaseLiabilityNetPaymentsDueYearTwo
|
739000 | |
CY2022 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
5470000 | |
CY2021 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
5360000 | |
CY2020 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
5360000 | |
CY2022 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
818000 | |
CY2021 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
910000 | |
CY2020 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
926000 | |
CY2022 | us-gaap |
Lease Cost
LeaseCost
|
6288000 | |
CY2021 | us-gaap |
Lease Cost
LeaseCost
|
6270000 | |
CY2020 | us-gaap |
Lease Cost
LeaseCost
|
6286000 | |
CY2022 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
10485000 | |
CY2021 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
10082000 | |
CY2020 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
9694000 | |
CY2022 | rigl |
Fixed Sublease Expense
FixedSubleaseExpense
|
4381000 | |
CY2021 | rigl |
Fixed Sublease Expense
FixedSubleaseExpense
|
4381000 | |
CY2020 | rigl |
Fixed Sublease Expense
FixedSubleaseExpense
|
4381000 | |
CY2022 | rigl |
Variable Sublease Expense
VariableSubleaseExpense
|
911000 | |
CY2021 | rigl |
Variable Sublease Expense
VariableSubleaseExpense
|
917000 | |
CY2020 | rigl |
Variable Sublease Expense
VariableSubleaseExpense
|
962000 | |
CY2022 | us-gaap |
Sublease Income
SubleaseIncome
|
5292000 | |
CY2021 | us-gaap |
Sublease Income
SubleaseIncome
|
5298000 | |
CY2020 | us-gaap |
Sublease Income
SubleaseIncome
|
5343000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
1534000 | |
CY2022Q4 | rigl |
Sublease Payments To Be Received Next Twelve Months
SubleasePaymentsToBeReceivedNextTwelveMonths
|
394000 | |
CY2022Q4 | rigl |
Lessee Operating Lease Liability Net Payments Next Twelve Months
LesseeOperatingLeaseLiabilityNetPaymentsNextTwelveMonths
|
1140000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
301000 | |
CY2022Q4 | rigl |
Lessee Operating Lease Liability Net Payments Due Year Three
LesseeOperatingLeaseLiabilityNetPaymentsDueYearThree
|
301000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
2574000 | |
CY2022Q4 | rigl |
Sublease Payments To Be Received
SubleasePaymentsToBeReceived
|
394000 | |
CY2022Q4 | rigl |
Lessee Operating Lease Liability Net Payments
LesseeOperatingLeaseLiabilityNetPayments
|
2180000 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
600000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
230373000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
229364000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
68646000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
66616000 | |
CY2022Q4 | rigl |
Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
|
15680000 | |
CY2021Q4 | rigl |
Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
|
150000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
11234000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
16297000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
|
9620000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
|
8819000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
2494000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1523000 | |
CY2022Q4 | rigl |
Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
|
504000 | |
CY2021Q4 | rigl |
Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
|
2564000 | |
CY2022Q4 | rigl |
Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
|
461000 | |
CY2021Q4 | rigl |
Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
|
2335000 | |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
439000 | |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
607000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
337651000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
322391000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
337651000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
322391000 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.000 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.028 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.001 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.202 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.275 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.244 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.025 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.056 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.047 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.026 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.140 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.127 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.010 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.027 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.046 | |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.001 | |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.036 | |
CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.001 | |
CY2022 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
15300000 | |
CY2021 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
6600000 | |
CY2020 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
4100000 | |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
9186000 | |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
8901000 | |
CY2019Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
8358000 | |
CY2022 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
240000 | |
CY2021 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
285000 | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
543000 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
9426000 | |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
9186000 | |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
8901000 | |
CY2022 | us-gaap |
Restructuring Charges
RestructuringCharges
|
1300000 | |
CY2021 | us-gaap |
Restructuring Charges
RestructuringCharges
|
3500000 |